Overview
American Board of Psychiatry and Neurology
Neurology (#61445), 09/24/2018
American Board of Electrodiagnostic Medicine
Electrodiagnostic Medicine (#4137), 2020
Neuromuscular Ultrasound Certificate of Added Qualification (#84), 2023
American Board of Psychiatry and Neurology
Neuromuscular Disorders (# 914), 10/19/2020UCB Pharmaceuticals/Duke/UNC Neurology Clinical Drug 07/2019 - 09/2021
Raleigh, NC/Durham, NC Development FellowshipCurrent Appointments & Affiliations
Assistant Professor of Neurology
·
2021 - Present
Neurology, Neuromuscular Disease,
Neurology
Recent Publications
Quantitative muscle ultrasound as a window into disease progression in infantile-onset Pompe disease.
Journal Article Mol Genet Metab · November 2025 BACKGROUND: Infantile-onset Pompe disease (IOPD) is caused by a deficiency of the enzyme acid alfa glucosidase, resulting in glycogen accumulation in muscles and other tissues. Without treatment, affected infants typically die within two years. Enzyme repl ... Full text Link to item CiteMYOSITIS COMMUNITY PROPOSES A FRAMEWORK TO GUIDE CLINICAL TRIALS AND ENSURE PATIENT SAFETY DURING INFLUX OF CAR-BASED THERAPIES
Conference ANNALS OF THE RHEUMATIC DISEASES · 2025 Full text CiteClinical Reasoning: A 60-Year-Old Woman With Rapidly Progressive Muscle Weakness and Ophthalmoparesis.
Journal Article Neurology · August 13, 2024 The clinical assessment of patients with proximal muscle weakness represents a frequent yet intricate challenge. We present the case of a 60-year-old woman who experienced a progressive, symmetrical weakness in proximal limbs and bulbar muscles over 6 mont ... Full text Link to item CiteRecent Grants
A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1
Clinical TrialPrincipal Investigator · Awarded by Avidity Biosciences · 2025 - 2028A Phase 3 Randomized, Double-Blind, Placebo[1]Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1
Clinical TrialPrincipal Investigator · Awarded by Avidity Biosciences · 2024 - 2027Nerve Ultrasound for Diagnosis and Prognosis of GBS
ResearchPrincipal Investigator · Awarded by GBS/CIDP Foundation International · 2020 - 2023View All Grants
Education, Training & Certifications
Penn State Milton S. Hershey Medical Center ·
2014
M.D.